Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1979-01-22
1981-04-28
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 424 12, 424177, 260112R, 260112B, G01N 3348, G01T 100, A61K 4300, C07G 700
Patent
active
042645719
ABSTRACT:
An immunoassay for the polypeptidic thymic hormone thymosin .alpha..sub.1 is described. Determination of thymosin .alpha..sub.1 levels in biological fluids, particularly serum, provides a useful diagnostic test for immune deficiency diseases, autoimmune diseases, immunologically mediated diseases, neoplastic diseases and also allows one to monitor therapy with thymosin .alpha..sub.1 by following blood levels of the hormone.
REFERENCES:
patent: 4002740 (1977-01-01), Goldstein et al.
patent: 4010148 (1977-03-01), Goldstein et al.
patent: 4082737 (1978-04-01), McGregor et al.
patent: 4148788 (1979-04-01), Wang
Goldstein Allan L.
McClure John E.
George Washington University
Gould George M.
Leon Bernard S.
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Radioimmunoassay of thymosin .alpha..sub.1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioimmunoassay of thymosin .alpha..sub.1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioimmunoassay of thymosin .alpha..sub.1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-863865